N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine

C64H72N20OS3 — CID 158212036

IUPACN-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine
SMILESCCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)c(OC)c3)cs2)c1C.CCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)nc3)cs2)c1C.Cc1cn(-c2ccc(-c3csc(Nc4c(C)c(C(C)C)nn4C)n3)cn2)cn1
InChIInChI=1S/C23H26N6OS.C21H23N7S.C20H23N7S/c1-5-18-15(3)22(29(27-18)17-7-8-17)26-23-25-19(12-31-23)16-6-9-20(21(10-16)30-4)28-11-14(2)24-13-28;1-4-17-14(3)20(28(26-17)16-6-7-16)25-21-24-18(11-29-21)15-5-8-19(22-9-15)27-10-13(2)23-12-27;1-12(2)18-14(4)19(26(5)25-18)24-20-23-16(10-28-20)15-6-7-17(21-8-15)27-9-13(3)22-11-27/h6,9-13,17H,5,7-8H2,1-4H3,(H,25,26);5,8-12,16H,4,6-7H2,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24)
InChIKeyGCETVJKKYMQKOE-UHFFFAOYSA-N
MW1233.62 g/mol
LogP14.91
Rot. Bonds18

About N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine

N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine (PubChem CID 158212036) has the molecular formula C64H72N20OS3 and a molecular weight of 1233.62 g/mol. Its IUPAC name is N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine.

Molecular Properties

Compound NameN-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine
PubChem CID158212036
Molecular FormulaC64H72N20OS3
Molecular Weight1233.62 g/mol
Exact Mass1232.54
IUPAC NameN-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine
SMILESCCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)c(OC)c3)cs2)c1C.CCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)nc3)cs2)c1C.Cc1cn(-c2ccc(-c3csc(Nc4c(C)c(C(C)C)nn4C)n3)cn2)cn1
InChIInChI=1S/C23H26N6OS.C21H23N7S.C20H23N7S/c1-5-18-15(3)22(29(27-18)17-7-8-17)26-23-25-19(12-31-23)16-6-9-20(21(10-16)30-4)28-11-14(2)24-13-28;1-4-17-14(3)20(28(26-17)16-6-7-16)25-21-24-18(11-29-21)15-5-8-19(22-9-15)27-10-13(2)23-12-27;1-12(2)18-14(4)19(26(5)25-18)24-20-23-16(10-28-20)15-6-7-17(21-8-15)27-9-13(3)22-11-27/h6,9-13,17H,5,7-8H2,1-4H3,(H,25,26);5,8-12,16H,4,6-7H2,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24)
InChIKeyGCETVJKKYMQKOE-UHFFFAOYSA-N
XLogP14.91
TPSA216.69 Ų
H-Bond Donors3
H-Bond Acceptors24
Rotatable Bonds18
Heavy Atoms88
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001233.62
LogP ≤ 514.91
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1024

Analyze N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(3-tert-butyl-1-ethylpyrazol-5-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine
CID 54758492
gamma-Secretase modulator 5
CID 56592447
4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-N-(2-methyl-4,5,6,7-tetrahydroindazol-3-yl)-1,3-thiazol-2-amine
CID 56592448
N-[2-(2-methoxyethyl)-4,5,6,7-tetrahydroindazol-3-yl]-4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-1,3-thiazol-2-amine
CID 86275158
N-(2-ethyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-3-yl)-4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-1,3-thiazol-2-amine
CID 86275159
4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-N-[2-(2-morpholin-4-ylethyl)-4,5,6,7-tetrahydroindazol-3-yl]-1,3-thiazol-2-amine
CID 86275160
N-(1-ethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-1,3-thiazol-2-amine
CID 88875716
4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-N-(2-methyl-4,5,6,7-tetrahydroindazol-3-yl)-1,3-thiazol-2-amine
CID 89657804
N-(2-ethyl-4,5,6,7-tetrahydroindazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine
CID 89657805
N-(3-tert-butyl-1-methylpyrazol-5-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine
CID 89657811
4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-N-(2-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-3-yl)-1,3-thiazol-2-amine
CID 118684957
N-[1-ethyl-3-(1-methylcyclopropyl)pyrazol-5-yl]-4-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-1,3-thiazol-2-amine
CID 118684958

Frequently Asked Questions

What is the IUPAC name of N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine?
The IUPAC name of N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine (CID 158212036) is N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine.
What is the SMILES notation for N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine?
The canonical SMILES for N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine is CCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)c(OC)c3)cs2)c1C.CCc1nn(C2CC2)c(Nc2nc(-c3ccc(-n4cnc(C)c4)nc3)cs2)c1C.Cc1cn(-c2ccc(-c3csc(Nc4c(C)c(C(C)C)nn4C)n3)cn2)cn1.
What is the InChIKey of N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine?
The InChIKey is GCETVJKKYMQKOE-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26N6OS.C21H23N7S.C20H23N7S/c1-5-18-15(3)22(29(27-18)17-7-8-17)26-23-25-19(12-31-23)16-6-9-20(21(10-16)30-4)28-11-14(2)24-13-28;1-4-17-14(3)20(28(26-17)16-6-7-16)25-21-24-18(11-29-21)15-5-8-19(22-9-15)27-10-13(2)23-12-27;1-12(2)18-14(4)19(26(5)25-18)24-20-23-16(10-28-20)15-6-7-17(21-8-15)27-9-13(3)22-11-27/h6,9-13,17H,5,7-8H2,1-4H3,(H,25,26);5,8-12,16H,4,6-7H2,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24).
What are the key properties of N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine?
N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine has a molecular weight of 1233.62 g/mol, XLogP of 14.91, 18 rotatable bonds, 3 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine;N-(2-cyclopropyl-5-ethyl-4-methylpyrazol-3-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine;N-(1,4-dimethyl-3-propan-2-ylpyrazol-5-yl)-4-[6-(4-methylimidazol-1-yl)-3-pyridinyl]-1,3-thiazol-2-amine is sourced from PubChem (CID 158212036), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).